wow, took you that long to come to that conclusion.... It took me 2 comments to see that he and the Wolf Pack.... Suffer from APHANTASIA....
Its Not Nice to hit on the weak... Ignorance is bliss on this one
Last edited:
Will you take the COVID-19 vaccine?
- Thread starter probyn
- Start date
- Status
Its Not Nice to hit on the weak... Ignorance is bliss on this one
Developers of Oxford-AstraZeneca Vaccine Tied to UK Eugenics Movement
The developers of the Oxford-AstraZeneca vaccine have previously undisclosed ties to the re-named British Eugenics Society as well as other Eugenics-linked institutions like the Wellcome Trust.
On April 30th, AstraZeneca and Oxford University announced a “landmark agreement” for the development of a COVID-19 vaccine. The agreement involves AstraZeneca overseeing aspects of the development as well as manufacturing and distribution while the Oxford side, via the Jenner Institute and Oxford Vaccine Group, researched and developed the vaccine. Less than a month after this agreement was reached, the Oxford-AstraZeneca partnership was awarded a contract from the US government as part of Operation Warp Speed, the public-private COVID-19 vaccination effort dominated by the US military and US intelligence.
Though the partnership was announced in April, Oxford’s Jenner Institute had already begun developing the COVID-19 vaccine months before, in mid-January. According to a recent BBC report, it was in January that the Jenner Institute first became aware of how serious the pandemic would soon become, when Professor Andrew Pollard, who works for both the Jenner Institute and heads the Oxford Vaccine Group, “shared a taxi with a modeler who worked for the UK’s Scientific Advisory Group for Emergencies.” During the taxi ride, “the scientist told him data suggested there was going to be a pandemic not unlike the 1918 flu.” Due to this sole encounter, we are told, the Jenner Institute then began to pour millions into the early development of a vaccine for COVID-19 well before the scope of the crisis was clear.
For much of 2020, the Oxford-AstraZeneca vaccine was treated as an early front-runner, though its lead would later be marred by scandals related to its clinical trials, including the death of participants, sudden trial pauses, the use of a problematic “placebo” with its own host of side effects and the “unintentional” mis-dosing of some participants that skewed its self-reported efficacy rate.
The significant issues that emerged during trials have provoked little concern from the vaccine’s two lead developers, despite critical attention from even mainstream media of its complications. The lead developer of the Oxford-AstraZeneca vaccine, Adrian Hill, told NBC on December 9th that the experimental vaccine should be approved and distributed to the public before the conclusion of the safety trials, saying,”to wait for the end of the trial would be the middle of next year. That’s too late, this vaccine is effective, available at large scale and easily deployed.”
Sarah Gilbert, the other lead researcher on the vaccine, seemed to believe that pre-mature safety approval was likely, telling the BBC on December 13 that the chances of rolling out the vaccine by the end of the year are “pretty high.” Now, the UK is expected to approve the Oxford-AstraZeneca vaccine shortly after Christmas, with India also set to approve the vaccine next week.
While the controversies surrounding the vaccine’s trials did ultimately undermine its previous frontrunner status, the Oxford-AstraZeneca vaccine remains heavily promoted as the vaccine of choice for the developing world, as it is cheaper and has much less complicated storage requirement than its main competitors, Pfizer and Moderna.
Earlier this month, Dr. Richard Horton, the editor-in-chief of the Lancet medical journal, told CNBC that “The Oxford AstraZeneca vaccine is the vaccine right now that is going to be able to immunize the planet more effectively, more rapidly than any other vaccine we have” in large part because it is a “vaccine that can get to lower middle-income countries.” CNBC also quoted Andrew Baum, global head of health care for Citi Group, as saying that the Oxford-AstraZeneca vaccine “is really the only vaccine that is going to suppress or even eradicate SARS-CoV-2, the virus that causes COVID-19, in the many millions of individuals in the developing world.”
In addition to longstanding claims that the Oxford-AstraZeneca vaccine will be the vaccine of choice for the developing world, this vaccine candidate has also been treated by several outlets in the mainstream and even independent media as “good for people, bad for profits” due to the partnership’s “explicit intention of supplying [the vaccine] around the world on a not-for-profit basis, meaning that the poorest nations on the planet will not have to worry about being shut out of a cure due to lack of funds.”
However, investigation into the vaccine’s developers and the realities of their “no-profit pledge” reveals a very different story than that which has been spun for most of the year by corporate press releases, experts and academics tied to the vaccine and the mainstream press.
For instance, mainstream media has had little, if anything, to say about the role of the vaccine developers’ private company – Vaccitech – in the Oxford-AstraZeneca partnership, a company whose main investors include former top Deutsche Bank executives, Silicon Valley behemoth Google and the UK government. All of them stand to profit from the vaccine alongside the vaccine’s two developers, Adrian Hill and Sarah Gilbert, who retain an estimated 10% stake in the company. Another overlooked point is the plan to dramatically alter the current sales model for the vaccine following the initial wave of its administration, which would see profits soar, especially if the now obvious push to make COVID-19 vaccination an annual affair for the foreseeable future is made reality.
Yet, arguably most troubling of all is the direct link of the vaccine’s lead developers to the Wellcome Trust and, in the case of Adrian Hill, the Galton Institute, two groups with longstanding ties to the UK Eugenics movement. The latter organization, named for the “father of eugenics” Francis Galton, is the re-named UK Eugenics Society, a group notorious for its promotion of racist pseudoscience and efforts to “improve racial stock” by reducing the population of those deemed inferior for over a century.
The ties of Adrian Hill to the Galton Institute should raise obvious concerns given the push to make the Oxford-AstraZeneca vaccine he developed with Gilbert the vaccine of choice for the developing world, particularly countries in Latin America, South and Southeast Asia and Africa, the very areas where the Galton Institute’s past members have called for reducing population growth.
In the final installment of this series on Operation Warp Speed, the US government’s vaccination effort, and race, the Oxford-AstraZeneca vaccine’s ties to Eugenics-linked institutions, the secretive role of Vaccitech, and the myth of the vaccine’s sale being “non-profit” and altruistically motivated are explored in detail.
GlaxoSmithKline and the Jenner Institute
The Edward Jenner Institute for Vaccine Research was initially established in 1995 in Compton in Berkshire as a public-private partnership between the UK government, via the Medical Research Council and the Department of Health, and the pharmaceutical giant GlaxoSmithKline. Following a “review by the [institute’s] sponsors,” it was relaunched in 2005 in Oxford under the leadership of Adrian Hill, who—prior to that appointment—held a senior position at the Wellcome Trust’s Centre for Human Genetics. Hill, the lead developer of the Oxford-AstraZeneca COVID-19 vaccine, still leads a research group at Wellcome aimed at “understand[ing] the genetic basis of susceptibility to different infectious diseases, especially. . . severe respiratory infections,” which conducts most of its studies in Africa. The UK’s Medical Research Council has also become a collaborator with the Wellcome Trust, specifically on vaccine-related initiatives. The Wellcome Trust, discussed at greater length later in this article, was originally created with funding from Henry Wellcome, who founded the company that later became GlaxoSmithKline.
Hill’s partner at the Jenner Institute and the other co-developer of the Oxford COVID-19 vaccine is Sarah Gilbert. Gilbert also hails from the Wellcome Trust, where she was a “program director,” and is a student of Hill’s. Together, Gilbert and Hill have worked to position the institute to be the center of all future vaccination efforts undertaken in response to global pandemics.
The Jenner Institute’s relocation to Oxford was largely facilitated by the Medical Research Council, which donated £1.25 million between 2005 and 2006, after the decision was made to replace the institute’s original sponsors (GlaxoSmithKline, the Medical Research Council, the Department of Health) with the University of Oxford and the Institute for Animal Health, now called the Pirbright Institute. The involvement of Pirbright meant that the relaunched Jenner Institute became unique in developing vaccines for both humans and livestock.
The relaunched Jenner Institute has come to dominate publicly funded vaccine development in the UK as well as the testing of vaccines produced by the world’s largest pharmaceutical companies via clinical trials and has overseen prominent safety trials for vaccines of high media interest in recent years. Some of the Jenner Institute–conducted trials later draw controversy, such as those using South African infants in 2009 in which seven infants died.
An investigation conducted by the British Medical Journal found that the Hill-led Jenner Institute had, in the South African instance, knowingly misled parents about the negative results of and questionable methods used in animal studies as well the vaccine being known to be ineffective. The vaccine in question, an experimental tuberculosis vaccine developed jointly by Emergent Biosolutions and the Jenner Institute, was scrapped after the controversial study in infants confirmed what was already known, that the vaccine was ineffective. The trial, largely funded by Oxford and the Wellcome Trust, was subsequently praised as “historic” by the BBC. Hill, at the time the study was conducted, had a personal financial stake in the vaccine.
Similar instances of dodgy practices in efficacy trials and the effects of increased dosages have led vaccine experts to criticize the COVID-19 vaccine developed by Hill and Gilbert. Hill and Gilbert hold a considerable financial stake in the Oxford-AstraZeneca COVID-19 vaccine. While the vaccine reportedly has an efficacy of over 90 percent, those figures—often cited in mainstream reports—are self-reported by the vaccine’s developers and manufacturers (i.e., the Oxford team and AstraZeneca), which is significant given that Hill and other Jenner Institute scientists have previously been caught manipulating trial results to benefit a vaccine product in which they were personally invested.
The prominence of the Jenner Institute in vaccine development and testing has largely come through Hill’s additional leadership role at the UK’s Vaccines Network, which chooses what vaccines to develop, how to develop them, and which firms should receive “targeted investments” from the UK government. The Vaccines Network also plays a key role in identifying “what vaccine technologies could play an important role in future outbreaks.” Two of the main backers of the UK’s Vaccines Network are the Wellcome Trust and GlaxoSmithKline.
Unsurprisingly, the Vaccines Network has steered many millions of pounds toward the Hill-run Jenner Institute, with completed projects including a “plug and display” virus-like particle platform for rapid-response vaccination. Also funded by the Vaccines Network were the Jenner Institute’s initial studies of novel chimpanzee adenovirus vaccines for coronavirus (in this case, MERS), the same viral vector used for the Oxford-AstraZeneca vaccine. In addition to the Vaccines Network, the Jenner Institute also coordinates the efforts of the EU’s Vaccines Network equivalent, MultiMalVax.
more at
Developers of Oxford-AstraZeneca Vaccine Tied to UK Eugenics Movement - unlimitedhangout.com
The developers of the Oxford-AstraZeneca vaccine have previously undisclosed ties to the re-named British Eugenics Society as well as other Eugenics-linked institutions like the Wellcome Trust.
On April 30th, AstraZeneca and Oxford University announced a “landmark agreement” for the development of a COVID-19 vaccine. The agreement involves AstraZeneca overseeing aspects of the development as well as manufacturing and distribution while the Oxford side, via the Jenner Institute and Oxford Vaccine Group, researched and developed the vaccine. Less than a month after this agreement was reached, the Oxford-AstraZeneca partnership was awarded a contract from the US government as part of Operation Warp Speed, the public-private COVID-19 vaccination effort dominated by the US military and US intelligence.
Though the partnership was announced in April, Oxford’s Jenner Institute had already begun developing the COVID-19 vaccine months before, in mid-January. According to a recent BBC report, it was in January that the Jenner Institute first became aware of how serious the pandemic would soon become, when Professor Andrew Pollard, who works for both the Jenner Institute and heads the Oxford Vaccine Group, “shared a taxi with a modeler who worked for the UK’s Scientific Advisory Group for Emergencies.” During the taxi ride, “the scientist told him data suggested there was going to be a pandemic not unlike the 1918 flu.” Due to this sole encounter, we are told, the Jenner Institute then began to pour millions into the early development of a vaccine for COVID-19 well before the scope of the crisis was clear.
For much of 2020, the Oxford-AstraZeneca vaccine was treated as an early front-runner, though its lead would later be marred by scandals related to its clinical trials, including the death of participants, sudden trial pauses, the use of a problematic “placebo” with its own host of side effects and the “unintentional” mis-dosing of some participants that skewed its self-reported efficacy rate.
The significant issues that emerged during trials have provoked little concern from the vaccine’s two lead developers, despite critical attention from even mainstream media of its complications. The lead developer of the Oxford-AstraZeneca vaccine, Adrian Hill, told NBC on December 9th that the experimental vaccine should be approved and distributed to the public before the conclusion of the safety trials, saying,”to wait for the end of the trial would be the middle of next year. That’s too late, this vaccine is effective, available at large scale and easily deployed.”
Sarah Gilbert, the other lead researcher on the vaccine, seemed to believe that pre-mature safety approval was likely, telling the BBC on December 13 that the chances of rolling out the vaccine by the end of the year are “pretty high.” Now, the UK is expected to approve the Oxford-AstraZeneca vaccine shortly after Christmas, with India also set to approve the vaccine next week.
While the controversies surrounding the vaccine’s trials did ultimately undermine its previous frontrunner status, the Oxford-AstraZeneca vaccine remains heavily promoted as the vaccine of choice for the developing world, as it is cheaper and has much less complicated storage requirement than its main competitors, Pfizer and Moderna.
Earlier this month, Dr. Richard Horton, the editor-in-chief of the Lancet medical journal, told CNBC that “The Oxford AstraZeneca vaccine is the vaccine right now that is going to be able to immunize the planet more effectively, more rapidly than any other vaccine we have” in large part because it is a “vaccine that can get to lower middle-income countries.” CNBC also quoted Andrew Baum, global head of health care for Citi Group, as saying that the Oxford-AstraZeneca vaccine “is really the only vaccine that is going to suppress or even eradicate SARS-CoV-2, the virus that causes COVID-19, in the many millions of individuals in the developing world.”
In addition to longstanding claims that the Oxford-AstraZeneca vaccine will be the vaccine of choice for the developing world, this vaccine candidate has also been treated by several outlets in the mainstream and even independent media as “good for people, bad for profits” due to the partnership’s “explicit intention of supplying [the vaccine] around the world on a not-for-profit basis, meaning that the poorest nations on the planet will not have to worry about being shut out of a cure due to lack of funds.”
However, investigation into the vaccine’s developers and the realities of their “no-profit pledge” reveals a very different story than that which has been spun for most of the year by corporate press releases, experts and academics tied to the vaccine and the mainstream press.
For instance, mainstream media has had little, if anything, to say about the role of the vaccine developers’ private company – Vaccitech – in the Oxford-AstraZeneca partnership, a company whose main investors include former top Deutsche Bank executives, Silicon Valley behemoth Google and the UK government. All of them stand to profit from the vaccine alongside the vaccine’s two developers, Adrian Hill and Sarah Gilbert, who retain an estimated 10% stake in the company. Another overlooked point is the plan to dramatically alter the current sales model for the vaccine following the initial wave of its administration, which would see profits soar, especially if the now obvious push to make COVID-19 vaccination an annual affair for the foreseeable future is made reality.
Yet, arguably most troubling of all is the direct link of the vaccine’s lead developers to the Wellcome Trust and, in the case of Adrian Hill, the Galton Institute, two groups with longstanding ties to the UK Eugenics movement. The latter organization, named for the “father of eugenics” Francis Galton, is the re-named UK Eugenics Society, a group notorious for its promotion of racist pseudoscience and efforts to “improve racial stock” by reducing the population of those deemed inferior for over a century.
The ties of Adrian Hill to the Galton Institute should raise obvious concerns given the push to make the Oxford-AstraZeneca vaccine he developed with Gilbert the vaccine of choice for the developing world, particularly countries in Latin America, South and Southeast Asia and Africa, the very areas where the Galton Institute’s past members have called for reducing population growth.
In the final installment of this series on Operation Warp Speed, the US government’s vaccination effort, and race, the Oxford-AstraZeneca vaccine’s ties to Eugenics-linked institutions, the secretive role of Vaccitech, and the myth of the vaccine’s sale being “non-profit” and altruistically motivated are explored in detail.
GlaxoSmithKline and the Jenner Institute
The Edward Jenner Institute for Vaccine Research was initially established in 1995 in Compton in Berkshire as a public-private partnership between the UK government, via the Medical Research Council and the Department of Health, and the pharmaceutical giant GlaxoSmithKline. Following a “review by the [institute’s] sponsors,” it was relaunched in 2005 in Oxford under the leadership of Adrian Hill, who—prior to that appointment—held a senior position at the Wellcome Trust’s Centre for Human Genetics. Hill, the lead developer of the Oxford-AstraZeneca COVID-19 vaccine, still leads a research group at Wellcome aimed at “understand[ing] the genetic basis of susceptibility to different infectious diseases, especially. . . severe respiratory infections,” which conducts most of its studies in Africa. The UK’s Medical Research Council has also become a collaborator with the Wellcome Trust, specifically on vaccine-related initiatives. The Wellcome Trust, discussed at greater length later in this article, was originally created with funding from Henry Wellcome, who founded the company that later became GlaxoSmithKline.
Hill’s partner at the Jenner Institute and the other co-developer of the Oxford COVID-19 vaccine is Sarah Gilbert. Gilbert also hails from the Wellcome Trust, where she was a “program director,” and is a student of Hill’s. Together, Gilbert and Hill have worked to position the institute to be the center of all future vaccination efforts undertaken in response to global pandemics.
The Jenner Institute’s relocation to Oxford was largely facilitated by the Medical Research Council, which donated £1.25 million between 2005 and 2006, after the decision was made to replace the institute’s original sponsors (GlaxoSmithKline, the Medical Research Council, the Department of Health) with the University of Oxford and the Institute for Animal Health, now called the Pirbright Institute. The involvement of Pirbright meant that the relaunched Jenner Institute became unique in developing vaccines for both humans and livestock.
The relaunched Jenner Institute has come to dominate publicly funded vaccine development in the UK as well as the testing of vaccines produced by the world’s largest pharmaceutical companies via clinical trials and has overseen prominent safety trials for vaccines of high media interest in recent years. Some of the Jenner Institute–conducted trials later draw controversy, such as those using South African infants in 2009 in which seven infants died.
An investigation conducted by the British Medical Journal found that the Hill-led Jenner Institute had, in the South African instance, knowingly misled parents about the negative results of and questionable methods used in animal studies as well the vaccine being known to be ineffective. The vaccine in question, an experimental tuberculosis vaccine developed jointly by Emergent Biosolutions and the Jenner Institute, was scrapped after the controversial study in infants confirmed what was already known, that the vaccine was ineffective. The trial, largely funded by Oxford and the Wellcome Trust, was subsequently praised as “historic” by the BBC. Hill, at the time the study was conducted, had a personal financial stake in the vaccine.
Similar instances of dodgy practices in efficacy trials and the effects of increased dosages have led vaccine experts to criticize the COVID-19 vaccine developed by Hill and Gilbert. Hill and Gilbert hold a considerable financial stake in the Oxford-AstraZeneca COVID-19 vaccine. While the vaccine reportedly has an efficacy of over 90 percent, those figures—often cited in mainstream reports—are self-reported by the vaccine’s developers and manufacturers (i.e., the Oxford team and AstraZeneca), which is significant given that Hill and other Jenner Institute scientists have previously been caught manipulating trial results to benefit a vaccine product in which they were personally invested.
The prominence of the Jenner Institute in vaccine development and testing has largely come through Hill’s additional leadership role at the UK’s Vaccines Network, which chooses what vaccines to develop, how to develop them, and which firms should receive “targeted investments” from the UK government. The Vaccines Network also plays a key role in identifying “what vaccine technologies could play an important role in future outbreaks.” Two of the main backers of the UK’s Vaccines Network are the Wellcome Trust and GlaxoSmithKline.
Unsurprisingly, the Vaccines Network has steered many millions of pounds toward the Hill-run Jenner Institute, with completed projects including a “plug and display” virus-like particle platform for rapid-response vaccination. Also funded by the Vaccines Network were the Jenner Institute’s initial studies of novel chimpanzee adenovirus vaccines for coronavirus (in this case, MERS), the same viral vector used for the Oxford-AstraZeneca vaccine. In addition to the Vaccines Network, the Jenner Institute also coordinates the efforts of the EU’s Vaccines Network equivalent, MultiMalVax.
more at
Developers of Oxford-AstraZeneca Vaccine Tied to UK Eugenics Movement - unlimitedhangout.com
Is The Covid-19 Vaccine Safe? (forbes.com)
Is The Covid-19 Vaccine Safe?
On Friday, December 12, 2020, the United States Food and Drug Administration issued its first Emergency Use Authorization (EUA) for a Covid-19 vaccine. The FDA’s approval of this vaccine, developed by Pfizer, followed recent approvals of the same vaccine by the UK, Canada, Bahrain, Saudi Arabia and Mexico. Clinical trials have shown this mRNA-based vaccine, and a similar one produced by Moderna, to be between 90-95% effective in preventing Covid-19 infections.
Over the next week, 2.9 million doses of the Pfizer vaccine will be shipped throughout the United States, and first offered to health care workers, nursing home workers and nursing home home residents. The United States has suffered more than 298,000 deaths from Covid-19, with the worldwide total passing a staggering 1.6 million deaths. But now that an effective vaccine is on the way, many people find themselves worrying, “Is this vaccine safe?”
The name of the government program to create a Covid-19 vaccine, ‘Operation Warp Speed’, the politicization of the pandemic, and the speed in which these vaccines were created, have led many to question whether corners were cut and undue pressure brought to quickly bring a vaccine to market. This article is one of a series that will address the vaccines, what we know about their safety profile and their potential long-term effects of an mRNA vaccine.
A December 10, 2020 article in the New England Journal of Medicine detailed the safety and effectiveness of the Pfizer mRNA Covid-19 vaccine based on a clinical trial of individuals age 16 or older who were either healthy or had chronic, but stable, medical conditions. These medical conditions included, but were not limited to, HIV and Hepatis B or C. Excluded from this trial were people with a medical history of Covid-19, a diagnosis of an immunocompromising condition, pregnant individuals, and those being treated with immunosuppressive therapy.
Is The Covid-19 Vaccine Safe?
On Friday, December 12, 2020, the United States Food and Drug Administration issued its first Emergency Use Authorization (EUA) for a Covid-19 vaccine. The FDA’s approval of this vaccine, developed by Pfizer, followed recent approvals of the same vaccine by the UK, Canada, Bahrain, Saudi Arabia and Mexico. Clinical trials have shown this mRNA-based vaccine, and a similar one produced by Moderna, to be between 90-95% effective in preventing Covid-19 infections.
Over the next week, 2.9 million doses of the Pfizer vaccine will be shipped throughout the United States, and first offered to health care workers, nursing home workers and nursing home home residents. The United States has suffered more than 298,000 deaths from Covid-19, with the worldwide total passing a staggering 1.6 million deaths. But now that an effective vaccine is on the way, many people find themselves worrying, “Is this vaccine safe?”
The name of the government program to create a Covid-19 vaccine, ‘Operation Warp Speed’, the politicization of the pandemic, and the speed in which these vaccines were created, have led many to question whether corners were cut and undue pressure brought to quickly bring a vaccine to market. This article is one of a series that will address the vaccines, what we know about their safety profile and their potential long-term effects of an mRNA vaccine.
A December 10, 2020 article in the New England Journal of Medicine detailed the safety and effectiveness of the Pfizer mRNA Covid-19 vaccine based on a clinical trial of individuals age 16 or older who were either healthy or had chronic, but stable, medical conditions. These medical conditions included, but were not limited to, HIV and Hepatis B or C. Excluded from this trial were people with a medical history of Covid-19, a diagnosis of an immunocompromising condition, pregnant individuals, and those being treated with immunosuppressive therapy.
Grand County Coroner: Colorado Should Improve Classification Of COVID Deaths
Grand County's coroner says her investigation into a murder-suicide wasn't finalized when the State of Colorado listed the two victims as dying with COVID-19.
denver.cbslocal.com
A 75 year old man from Beit Shean died Monday morning from cardiac arrest, about 2 hours after receiving the Pfizer Covid-19 vaccine.
The man received the vaccine at 8:30 in the morning, and waited for the customary time at the health clinic before he was released to his home feeling well.
Some time later, the man lost consciousness and was later confirmed dead from heart failure.
The Health Ministry said, "A 75-year-old man from the north of the country suffering from active heart disease and malignant disease, who has undergone a number of heart attacks, was vaccinated this morning against the coronavirus and died at home shortly after the procedure."
"The Director General of the Ministry of Health, Prof. Hezi Levy, has appointed a case investigation committee headed by the head of the Safety and Quality Division in the Ministry of Health.
"We share in the family's grief," the ministry said, adding that "Initial examination does not show a link between the unfortunate incident and the vaccination."
"The vaccination campaign continues," it stated.
75-year-old Israeli man dies 2 hours after getting Covid-19 vaccine - Technology & Health - Israel National News
The man received the vaccine at 8:30 in the morning, and waited for the customary time at the health clinic before he was released to his home feeling well.
Some time later, the man lost consciousness and was later confirmed dead from heart failure.
The Health Ministry said, "A 75-year-old man from the north of the country suffering from active heart disease and malignant disease, who has undergone a number of heart attacks, was vaccinated this morning against the coronavirus and died at home shortly after the procedure."
"The Director General of the Ministry of Health, Prof. Hezi Levy, has appointed a case investigation committee headed by the head of the Safety and Quality Division in the Ministry of Health.
"We share in the family's grief," the ministry said, adding that "Initial examination does not show a link between the unfortunate incident and the vaccination."
"The vaccination campaign continues," it stated.
75-year-old Israeli man dies 2 hours after getting Covid-19 vaccine - Technology & Health - Israel National News
So? It was also reported that he had a sip of water just prior to his heart attack. That's probably what killed him.
Are you willing to bet your life on that?So? It was also reported that he had a sip of water just prior to his heart attack. That's probably what killed him.
Court decides that quarantine in state of alert is illegal
The PCR test “is unable to determine, beyond reasonable doubt, that such positivity result corresponds, in fact, to the infection of a person by the SARS-CoV-2 virus”, said the Lisbon Court of Appeal.
www.theportugalnews.com
Water can easily do that, but like everything else the conditions would have to be right. Like his body would of needed to be extremely acid. Zero Food intake as liquid as well. Then a 2 cup of cold water drink fast. And it could easily happen.So? It was also reported that he had a sip of water just prior to his heart attack. That's probably what killed him.
But it s obviously the vax, after all its experimental. An in order to the logic of a vaccine! It has a virus inside. Along with heavy toxins. What could go wrong!...
After weeks of doubting the covid vaccine was anything more than a placebo, we "suddenly" have discovered a "new" strain of covid
This strain is (of course) unaffected by first vaccine
So why would anyone take the vaccine at this point?
This strain is (of course) unaffected by first vaccine
So why would anyone take the vaccine at this point?
Irish Government Admits: COVID-19 Does NOT Exist | Principia Scientific Intl.
After months of painstaking freedom of information law requests the government of Ireland has finally come clean and admitted that it has no scientific proof that the SARS-CoV-2 virus (COVID-19) exists. Which other nations are going to be next and admit this pandemic was a scam? "AS PART OF OUR...
principia-scientific.com
Court order!, see they were forced to show proof!. Guess what! they found out what we all knew. They havent a clue to what CV IS....
Johnson knew about new Covid-19 strain in SEPTEMBER. Why did he delay action until now? - Vox Political
Johnson dithered and now we must all take the damage. […]
voxpoliticalonline.com
So they knew in Sept, but only panic in dec. New, but 3 month old!
Next we gonna see Tinker Fraudci! & Peter Gates shit covid gold out of there hole!
Hahaha. Uninformed fear mongering.
You have no idea what you are talking about. From the Mayo Clinic website:
Can a COVID-19 vaccine give you COVID-19?
No. The COVID-19 vaccines currently being developed in the U.S. don't use the live virus that causes COVID-19.
When I read something like that, I know you don't have a clue. But there's no point in arguing with someone who has no interests in facts. Like the list of ingredients in the vaccine which is published. Containing "heavy toxins" is laughable.
Care to explain how several people who were part of the initial vaccine testing died when they were given the placebo? News flash, it had nothing to do with their death. It's called a coincidence. Just like the 75 year old who died 2 hours after getting the vaccine. It was a coincidence, and more coincidences with occur.
Currently about 655,000 Americans die from heart disease each year. What are you going to do now. Blame every naturally occurring heart related death on the vaccine, if they die after they've been vaccinated? You make no sense...
Ok, What do you think a placebo is? Nothing (water in a vaccine)? Or is it more like a meningitis vaccine. Part of the report-
Another source told Reuters the trial would have been suspended if the volunteer had received the coronavirus vaccine, suggesting the person was part of the control group that was given a meningitis vaccine.
Full Report Metro! mainstream -
Vaccine guinea pig, 28, dead from Covid complications - but trials will go on
An independent review found there were 'no safety concerns' with the vaccine and it is believed the participant had a placebo dose.
metro.co.uk
The pharmaceutical corporation Eli Lilly and Company gave thiomersal the trade name Merthiolate. It has been used as a preservative in vaccines, immunoglobulin preparations, skin test antigens, antivenins, ophthalmic
Thiomersal is very toxic by inhalation, ingestion, and in contact with skin (EC hazard symbol T+), with a danger of cumulative effects. It is also very toxic to aquatic organisms and may cause long-term adverse effects in aquatic environments (EC hazard symbol N).[21] In the body, it is metabolized or degraded to ethylmercury (C2H5Hg+) and thiosalicylate
Cases have been reported of severe mercury poisoning by accidental exposure or attempted suicide, with some fatalities.[22] Animal experiments suggest that thiomersal rapidly dissociates to release ethylmercury after injection; that the disposition patterns of mercury are similar to those after exposure to equivalent doses of ethylmercury chloride; and that the central nervous system and the kidneys are targets, with lack of motor coordination being a common sign. Similar signs and symptoms have been observed in accidental human poisonings. The mechanisms of toxic action are unknown.
If anyone calls you stupid there wrong! , your a fucking Idiot
An idiot, in modern use, is a stupid or foolish person. It was formerly a technical term in legal and psychiatric contexts for some kinds of profound intellectual disability where the mental age is two years or less, and the person cannot guard themself against common physical dangers.Wikipedia
He'll just say they're not telling the truth. Because it's their job to deceive the public. Truly laughable!
- Status
